Best Biopharma Outsourcing Companies in Missouri, United States

Manufacturer of antibodies, proteins, reagents, and kits for life science research. It provides antibodies, IVD products, proteins, and buffers and reagents. It offers products based on research area, application, and antigen. It also provides custom services such as antibody services, cell line development, protein and antibody lyophilization, protein production services, and conjugation services.

Provider of clinical data analytics services

Funding rounds

• Feb 2023Series A$6M

Founders & team

Edward WeinsteinCo-Founder and CEO

Investors

Telegraph Hill Partners, BioGenerator

Tech stack

BootstrapCloudflareCloudflare Bot ManagementContact Form 7CookieyesCore-Js

Spatial multi-omics solutions for accelerating life science research and discovery. They empower scientific breakthroughs with advanced spatial molecular solutions. The company provides instruments, assays, software, and services to support life sciences research from discovery to translation. They offer technologies for spatial proteomics, transcriptomics, and genomics, including platforms like CellScape, CosMx Spatial Molecular Imager, GeoMx Digital Spatial Profiler, and nCounter Analysis Platform. Their services cover spatial biology, single-cell analysis, and multiomics technologies. Applications span oncology, immunology, and neuroscience, enabling researchers to identify cancerous tissue, profile immune landscapes, and map neuronal structures. They provide resources like technical libraries, blogs, newsletters, and user support. This is a B2B tech company offering multiple products and services in the life sciences research space.

Reliable biopharma is engaged in manufacturing APIs and intermediates thereby supporting pharmaceutical and biotech companies. It also offers process development services. The company also offers speedy market approval through full project management including complex science, regulatory & analytical expertise. The company also manufactures laboratory reagents and standards

Nawgen is a biotech company that focuses on providing solutions and technology to life science research institutions, and Biotech and Pharmaceutical industries. Nawgen provides a variety of RNA products, including highly sensitive and specific miRNA qPCR assays, highly potent and specific miRNA CRISPR assays, and uniquely designed miRNA mimics. They also offer Experimental Services (Real-time PCR profiling for miRNA expression, RNA-seq profiling for miRNA expression, Knockout of miRNA genes by CRISPR/Cas9, Custom assay development for miRNA studies) and Data Analysis Services (Bioinformatics analysis of RNA-seq and microarray data, Combined bioinformatics and experimental analyses to identify miRNA functions).

Funding rounds

• Mar 2018Grant (prize money)$223.9K
• Sep 2015Grant (prize money)$697.1K
• Apr 2015Grant (prize money)$225K

Founders & team

Xiaowei WangFounderJim HoytCEO

Investors

HHS

Pharmaceutical services: API, formulation, manufacturing, and analytical development. This company offers comprehensive solutions for the pharmaceutical industry, specializing in API services, formulation development, contract manufacturing, and analytical development. They cater to diverse needs, including sterile injectables, potent formulations, nasal sprays, DEA regulated products, topical creams, liquids, tablets, capsules, and suppositories. Their manufacturing capabilities encompass small to medium-sized batches of prescription drug products in an FDA-inspected facility. They provide expertise in fine chemicals, biotech, and pharmaceutics, supporting clients from initial development to cGMP manufacturing. Their services are ideal for pharmaceutical companies seeking reliable partners for research, development, and manufacturing needs.

Drug discovery CRO providing tailored research solutions from idea to market. They are research partners specializing in complex biological systems, challenging drug targets, immuno-oncology, and preclinical/clinical biomarker development. They offer full-service support from initial concept to Investigational New Drug (IND) application, expediting timelines for pharmaceutical and biotech companies. Services include cell and molecular biology, biochemistry, enzymology, biomarker development, immunology, in vivo efficacy models, and medicinal chemistry. They provide custom-designed research, multi-platform assay options, and access to experienced scientists. Their expertise drives results in lead discovery, clinical candidate selection, and achieving marketed drugs. They are a contract research organization focused on advancing drug discovery research.

Funding rounds

• 2011Seed$75K

Founders & team

Joseph MonahanPresident & Co-Founder

Investors

BioGenerator

Tech stack

WordpressMysqlPhpZurb FoundationBootstrapAnimate.Css

Analytical testing lab ensuring patient safety for pharmaceutical and healthcare industries. It is an independent, privately owned commercial laboratory providing analytical and microbiological testing for sterile and non-sterile drug dosage forms and raw materials. The company supports pharmacies, pharmaceutical manufacturers, biotech, and healthcare organizations to safeguard and improve patient outcomes. They offer services like environmental monitoring, method development and validation, and other test services. Registered with the FDA, DEA, and licensed by the Bureau of Narcotics and Dangerous Drugs, as well as ISO accredited, they focus on delivering high-quality data with unparalleled customer support. Their commitment is to provide an Excellence in Testing experience through quality, customer service, and turnaround time. They partner with customers to address their unique challenges and drive success in the pharmaceutical industry.

Provider of risk assessment, consulting, and review services for biopharma sector

Gallus Biopharma, acquired by DPx Holdings, privately owned by JLL Partners and Royal DSM and the parent company of Patheon, was a biologics CDMO offering mammalian cell line based manufacturing services for drug developers. Their service portfolio included process development, analytical method development, process validation, quality assurance and regulatory affairs, cGMP manufacturing, fill/finish, project management services, stability testing, cell banking, and storage services. The company has 2 mammalian cell culture facilities in the US. It is currently part of Patheon’s biologic drug substance business which spans four global facilities in Europe, Australia and North America.